|Articles|June 9, 2021
Supplements and Featured Publications
- Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities
Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities
Advertisement
Although type 1 diabetes (T1D) includes a reasonably small patient population, it does impose a significant impact on patients, caregivers, payers, and society. This piece explores the history; physical, economic, and psychosocial burden; and clinical pathophysiology of T1D to evaluate opportunities for earlier intervention to change the standard of care for this disease and improve overall outcomes.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Pembrolizumab Plus Enfortumab Vedotin for MIBC
2
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
3
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
4
Trial Data Yield Risk-Based NRSTS Treatment Strategies
5











































